The molecular mechanism may inhibit the proliferation and survival of cancer cells by inhibiting the activation of the PI3K/AKT signaling pathway and the NFκB signaling pathway and simultaneously downregulating the expression of COX2 protein. The gene discussed is NFKB1; the disease is cancer.